Media Advisories



Cancer Research Catalyst Features Informative Posts for Media 1630627/24/2014 5:06:43 PM Advisories/AllItems.aspx8False2014-07-24T04:00:00Z<div class="ExternalClassA120B32A388B425FBDC43A4F8C9B5598"><p>​<em><a href="http&#58;//" target="_blank">Cancer Research Catalyst</a></em>, the blog of the American Association for Cancer Research (AACR), features two new posts this week on innovative science and opportunities for young researchers. <br><br>Srivani Ravoori, PhD, senior science writer, <a href="http&#58;//" target="_blank">explains</a> the science behind exceptional responders, where a patient has a unique response to a cancer treatment due to their genetic makeup. <br><br>Karen Honey, PhD, senior managing editor for science communications, <a href="http&#58;//" target="_blank">highlights</a> opportunities for young scientists to participate in AACR workshops that could shape the rest of their careers.<br><br>These posts are part of the continuing mission of Cancer Research Catalyst to further accelerate the growth and spread of knowledge about cancer, while providing helpful and interesting information to our members and the public. <br><br>Visit the blog at <a href="http&#58;//" target="_blank">http&#58;//</a> and subscribe. </p></div>
American Association for Cancer Research to Participate in Tomorrow’s Twitter Chat on the Promise of Immunotherapy45116/18/2014 7:22:54 PM Advisories/AllItems.aspx3False2014-06-05T04:00:00Z<div class="ExternalClass296BB431DC69415DA7DAA44CD9E690F2"><p>​The American Association for Cancer Research (AACR) will partner with Time magazine, Mayo Clinic Cancer Center, and Cancer Research Institute for a Twitter chat titled “The Promise of Immunotherapy,” Wednesday, June 18, 1-2 p.m. ET. <br><br>Immunotherapy is a unique approach to cancer treatment that restores the immune system’s ability to detect and eliminate cancer cells. <br><br>Esteban Celis, MD, PhD, a member of the AACR Cancer Immunology Steering Committee and professor of medicine at Georgia Regents University Cancer Center, will represent the AACR on this Twitter chat, which will be moderated by Time magazine’s Senior Health Reporter Alice Park. <br><br>Follow the conversation on Twitter and join us&#58; <a href="https&#58;//;q=%23CIMchat&amp;src=typd" target="_blank">#CIMchat</a><br><br>Follow the AACR on Twitter&#58; <a href="http&#58;//" target="_blank">@AACR</a><br><br>For more information, please contact Jeremy Moore at <a href="mailto&#58;" target="_blank"></a> or 215-446-7109, or Lauren Riley at <a href="mailto&#58;" target="_blank"></a> or 215-446-7155.</p></div>
AACR to Host Two Press Teleconferences at Pancreatic Cancer Conference 45126/18/2014 7:25:46 PM Advisories/AllItems.aspx4False2014-05-08T04:00:00Z<div class="ExternalClassAAF3F390810348FAA16DC418F4CCA4A1"><p>​NEW ORLEANS — The American Association for Cancer Research (AACR) will host two press teleconferences at its special conference on Pancreatic Cancer&#58; Innovations in Research and Treatment, May 18-21 at the Hyatt Regency New Orleans.<br><br>A press kit containing embargoed news releases and highlighted abstracts will be available to media May 13. <br><br><strong>First Teleconference</strong><br>The first teleconference will be held Monday, May 19, 10 a.m. CT. Reporters can dial in at 866-297-6395 (United States/Canada) or 847-944-7317 (international), and should offer confirmation code 37195596 when prompted. It will include&#58;&#160; </p><ul><li>Analyses projecting paradigm-shifting pancreatic cancer mortality rates;</li><li>Updated results of a phase Ib trial combining gemcitabine with a new radioimmunotherapy for metastatic pancreatic cancer;</li><li>Development and validation of a blood-based biomarker panel for detection of early-stage pancreatic cancer; and</li><li>Preclinical results indicating CD47 may be a therapeutic target for pancreatic neuroendocrine tumors and pancreatic ductal adenocarcinoma.</li></ul><p> <strong>Second Teleconference</strong><br>On Wednesday, May 21, 10 a.m. CT, conference leaders David Tuveson, M.D., Ph.D., The Lustgarten Foundation and Cold Spring Harbor Laboratories; Christine Iacobuzio-Donahue, M.D., Memorial Sloan Kettering Cancer Center; and Alec Kimmelman, M.D., Ph.D., Dana-Farber Cancer Institute, will offer analysis of the conference, including discussion of exciting new research areas and potential treatment options. <br><br>Reporters who join that press teleconference should dial 866-297-6395 (United States/Canada) or 847-944-7317 (international) and offer confirmation code 37264783 when prompted.&#160; </p><table align="center" class="mceItemTable" border="0"><tbody><tr><td><p><a href="https&#58;//;q=%23AACRPanCa14" target="_blank"><img title="#AACRPanCa14" alt="#AACRPanCa14" src="http&#58;//" border="0" style="margin&#58;5px;width&#58;50px;" /></a><br>&#160;</p></td><td><h4><a href="https&#58;//;q=%23AACRPanCa14" target="_blank">#AACRPanCa14</a></h4></td></tr></tbody></table></div>
Scientists From the American Association for Cancer Research Annual Meeting to Participate in ABC News' Twitter Chat on Personalized Medicine and the Latest in Cancer Research Breakthroughs 45136/18/2014 7:15:53 PM Advisories/AllItems.aspx5False2014-03-28T04:00:00Z<div class="ExternalClass6A328AFC2F7642A7B43B159B7DD28FE3"><p>​The American Association for Cancer Research (AACR) officers Charles Sawyers, M.D., and Scott Lowe, Ph.D., will be tweeting during the ABC News Twitter chat Tuesday, April 8, 1-2 p.m. ET, on the latest advances in cancer research, including personalized medicine, immunology, and genomics. The Twitter chat will be moderated by ABC News Medical Editor Richard Besser, M.D. &#160;<br><br>In addition to their leadership roles at Memorial Sloan Kettering Cancer Center in New York, Sawyers is president of the AACR and Lowe is program chairperson of the <a href="/Meetings/Pages/MeetingDetail.aspx?EventItemID=8">AACR Annual Meeting 2014</a>. They will join a panel of other AACR members at the AACR Annual Meeting 2014, where the latest and most exciting basic, translational, and clinical discoveries in cancer research are presented to more than 18,000 attendees.<br><br>Follow the conversation on Twitter and join in&#58; <a href="https&#58;//" target="_blank">#abcDrBchat</a>. <br><br>Follow the AACR on Twitter&#58; <a href="http&#58;//" target="_blank">@AACR</a>.</p></div>
American Association for Cancer Research to Host Annual Meeting in San Diego, April 5-9, 201445146/18/2014 7:18:33 PM Advisories/AllItems.aspx6False2014-02-26T05:00:00Z<div class="ExternalClassEA52CE4A5A6644F4B1DA9EF4B9796E50"><p>​SAN DIEGO – The American Association for Cancer Research (AACR) will showcase newsworthy research on clinical trials, epidemiology, immunology, epigenetics, laboratory science, and translational medicine at its Annual Meeting, April 5-9. &#160;<br><br>“This meeting is the most important venue for hearing the latest breakthroughs in cancer research both in the laboratory and in the clinic,” said AACR President Charles Sawyers, M.D., investigator at the Howard Hughes Medical Institute and chair of the Human Oncology and Pathogenesis Program at Memorial Sloan Kettering Cancer Center.<br><br>The meeting will draw more than 18,000 scientists, clinicians, advocates, and others to discuss advances in the field of cancer science. <br><br>Press conferences will be held at the following times&#58;</p><ul><li>Sunday, April 6, 2014, 7&#58;30 a.m. PT</li><li>Monday, April 7, 2014, 7&#58;30 a.m. PT</li><li>Tuesday, April 8, 2014, 7&#58;30 a.m. PT</li></ul><p>The press room will be located in room 15A of the San Diego Convention Center and will be open from 7 a.m. to 5 p.m., Saturday, April 5 to Tuesday, April 8, and 7 a.m. to 12 p.m., Wednesday, April 9. The press room is a fully functioning office with computers, printers, wireless internet access, and refreshments. <br><br>Those following on social media can join the conversation on Twitter at <a href="https&#58;//;src=hash&amp;f=realtime" target="_blank">#AACR14</a>.<br><br>For more information, contact Jeremy Moore at 215-446-7109 or <a href="mailto&#58;" target="_blank"></a>.</p></div>
American Association for Cancer Research to Participate in Upcoming Mayo Clinic Twitter Chat on Cancer Prevention45156/18/2014 7:20:47 PM Advisories/AllItems.aspx7False2014-02-24T05:00:00Z<div class="ExternalClass413C25387AB04F14BF899F8CC2EFC6AF"><p>​Leading cancer prevention expert Ernest Hawk, M.D., M.P.H., will be tweeting on behalf of the American Association for Cancer Research during this Twitter chat, which will be moderated by the PBS NewsHour, Thursday, Feb. 27, 1-2 p.m. ET. &#160;<a href="https&#58;//;f=realtime" target="_blank"></a><br><br>Hawk, a senior deputy editor of <em>Cancer Prevention Research</em>, a journal of the American Association for Cancer Research, is vice president and division head of Cancer Prevention and Population Sciences at The University of Texas MD Anderson Cancer Center in Houston, Texas. <br><br>He will join a panel of medical experts from the Mayo Clinic to discuss cancer risk from genetics, lifestyle choices, and environmental factors and how these risks can be mitigated by good nutrition, exercise, and screening. <br><br>Follow the conversation on Twitter and join us&#58; <a href="https&#58;//;f=realtime" target="_blank"><span style="text-decoration&#58;underline;"><font color="#0066cc">#NewsHourChats</font></span></a>. <br><br>Follow the AACR on Twitter&#58; <a href="http&#58;//" target="_blank"><span style="text-decoration&#58;underline;"><font color="#0066cc">@AACR</font></span></a>.<br><br>For more information, please contact Jeremy Moore at <a href="mailto&#58;"><span style="text-decoration&#58;underline;"><font color="#0066cc"></font></span></a> or 267-250-5441.</p></div>